Document text
Principal Investigator: ALAN Ira FADEN
Organization: UNIVERSITY OF MARYLAND BALTIMORE
Fiscal Year: 2024
Award: $620,399
Funding agency: National Institute of Neurological Disorders and Stroke
Traumatic brain injury (TBI) causes chronic neuroinflammation with progressive neurodegeneration and may ultimately lead to Alzheimer’s disease and/or Alzheimer’s Disease-related dementia and long-term neurocognitive dysfunctions. Emerging evidence suggests that bi-directional brain-systemic interactions contribute to these neuropathological changes. Notably, TBI causes gastrointestinal (GI) tract pathology and GI diseases are associated with neurological dysfunctions. We hypothesize that brain trauma and colitis interact to promote a persistent microglia dysregulation/neuroinflammation that drives the development of Alzheimer’s disease-type neuropathology with progressive tissue loss and cognitive decline.
TBI-induced GI damage is common, correlates with injury severity and may include mucosal injury, intestinal barrier disruption and dysmotility. The enteric nervous system (ENS) and enteric glial cells (EGCs) regulate mucosal barrier homeostasis. We reported that moderate controlled cortical impact (CCI) in mice, a well-characterized experimental TBI model, induces increased EGCs gliogenesis/reactivity and causes delayed, chronic mucosal barrier dysfunction in the colon. These changes may explain the increased risk for enteric infections in brain trauma patients. Moreover, an enteric infection during the chronic period after TBI resulted in increased colonic mucosal barrier impairment compared to infections in non-injured animals. Importantly, the enteric infection positively interacted with TBI secondary injury mechanisms and significantly exacerbated posttraumatic neuroinflammation and related neurodegeneration.
Late-onset Alzheimer’s Disease is the most common human neurodegenerative disease; however, a proper understanding of the underlaying processes as well as the availability and efficacy of disease-modifying interventions is lacking. Alzheimer’s Disease is a polygenic and environmentally influenced disease with many risk factors acting in concert to produce disease processes. The strongest genetic risk factors include the 4 allele of apolipoprotein E (APOE4) and point mutations in triggering receptor expressed on myeloid cells 2 (TREM2) locus. Clinical studies have found that traumatic brain injury (TBI) is associated with an increased risk for subsequent development of Alzheimer’s Disease. Furthermore, our preliminary data show that microglia, the principal TREM2 expressing cell population in the brain, undergo a persistent shift toward activated phenotypes following TBI that are characterized by both TREM2 and ApoE overexpression. Intriguingly, increasing evidence suggests that reciprocal communication between the enteric and the central nervous system, termed the brain-gut axis, plays a key role in neurodegenerative disease. Thus, population-based cohort studies demonstrate a significant association between inflammatory bowel diseases (IBD) and subsequent development of dementia. Importantly, among dementia types, the risk of developing Alzheimer’s dementia demonstrated the greatest increase in IBD patients compared to controls.
We propose that, mild-TBI and colitis synergize to promote the development of chronic neurodegenerative processes, causing delayed central inflammation, hippocampal neuronal loss and neurobehavioral dysfunctions and manifesting as Alzheimer’s disease-type neuropathology. A critical question is what underlying mechanisms drive the brain-gut pathological interactions after TBI and lead to chronic neuroinflammation, neurodegeneration and neurocognitive deficits that result in an Alzheimer’s disease and/or Alzheimer’s Disease-related dementia. The proposed studies will probe the novel concept that therapeutic strategies that target GI tract mechanisms may limit brain disease processes, including neurodegeneration, and thus attenuate chronic cognitive decline and the development of Alzheimer’s disease-type neuropathology after TBI.
Our central hypotheses are: 1) TBI causes chronic dysfunctions in brain-gut axis, priming increased pathological responses after late enteric challenges including activation in microglia of molecular responses such as Trem2 and ApoE, which are known to play important roles in the progression of Alzheimer’s disease; 2) Targeting ENS/EGCs or microglial activity promotes brain-gut homeostasis, attenuating brain neuroinflammation and specific microglial mechanisms that may drive Alzheimer’s disease-like processes, thus reducing dementia, neurodegeneration and neurocognitive deficits.
AIM1: Elucidate the mechanisms of chronic EGCs changes after mouse TBI and demonstrate that EGC modulators attenuate enteric pathology and neuropathology in the chronic phase after TBI.
AIM2: Examine the ability of ECGs activity modulators to limit colon injury and neurodegeneration after combined mild-TBI+colitis.
AIM3: Show that mild-TBI primes central microglia to develop a dysfunctional pro-inflammatory response to a later enteric challenge.
Terms: <AD dementia><AD related dementia><ADRD><Acute><Affective><Alimentary Canal><Alleles><Allelomorphs><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><Ammon Horn><Animals><Apo-E><ApoE><ApoE protein><Apolipoprotein E><Attenuated><Autoregulation><Body Tissues><Brain><Brain Diseases><Brain Disorders><Brain Inflammation><Brain Nervous System><Brain Pathology><Brain Trauma><CNS Nervous System><Cell Body><Cells><Central Nervous System><Chronic><Chronic Phase><Clinical Research><Clinical Study><Cognition><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive deficits><Cognitive function abnormal><Cohort Studies><Colitis><Colon><Colon Injury><Communication><Concurrent Studies><Cornu Ammonis><Cranial Nerve X><DREADDs><Data><Degenerative Neurologic Disorders><Dementia><Development><Digestive Tract><Disease><Disorder><Disturbance in cognition><Dysautonomias><Dysfunction><ECG><EKG><Electrocardiogram><Electrocardiography><Encephalitis><Encephalon><Encephalon Diseases><Engineering><Enteral><Enteric><Enteric Nervous System><Environment><Equilibrium><Functional disorder><G Protein-Complex Receptor><G Protein-Coupled Receptor Genes><G-Protein-Coupled Receptors><GI Tract><GPCR><Gastrointestinal Diseases><Gastrointestinal Tract><Gastrointestinal tract structure><Genetic><Genetic predisposing factor><Glia><Glial Cells><Hippocampus><Homeostasis><Hortega cell><Human><IQ Deficit><Immune><Immune response><Immunes><Immunological response><Impaired cognition><Impairment><Individual><Infection><Inflammation><Inflammatory><Inflammatory Bowel Diseases><Inflammatory Bowel Disorder><Inflammatory Response><Injury><Intervention><Intervention Strategies><Intestinal><Intestines><Intracranial CNS Disorders><Intracranial Central Nervous System Disorders><Kolliker's reticulum><Late Onset Alzheimer Disease><MTBI><Memory><Mice><Mice Mammals><Microglia><Modeling><Modern Man><Molecular><Motor><Mucosa><Mucosal Tissue><Mucous Membrane><Murine><Mus><Nerve Degeneration><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neuraxis><Neurocognitive><Neurocognitive Deficit><Neurodegenerative Diseases><Neurodegenerative Disorders><Neuroglia><Neuroglial Cells><Neurologic Deficit><Neurologic Degenerative Conditions><Neurologic Dysfunctions><Neuron Degeneration><Non-neuronal cell><Nonneuronal cell><Pathologic><Pathology><Pathway interactions><Patients><Phenotype><Physiological Homeostasis><Physiopathology><Play><Pneumogastric Nerve><Point Mutation><Population><Predisposition><Primary Senile Degenerative Dementia><Process><Receptor Protein><Regulation><Reporting><Resistance><Risk><Risk Factors><Role><Severities><Susceptibility><TREM2><TREM2 gene><Tenth Cranial Nerve><Therapeutic><Tissues><Trauma patient><Traumatic Brain Injury><Triggering Receptor Expressed in Myeloid Cells 2><Triggering Receptor Expressed on Myeloid Cells 2><Vagus Nerve><Vagus nerve structure><alimentary tract><attenuate><attenuates><balance><balance function><bowel><cholinergic><clinical relevance><clinically relevant><cognitive defects><cognitive dysfunction><cognitive function><cognitive loss><compare to control><comparison control><controlled cortical impact><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><designer receptors exclusively activated by designer drugs><developmental><digestive canal><dysmotility><dysmotility syndrome><enteral infection><enteric infection><enteric pathogen infection><enteropathogen infection><enteropathogenic infection><gastrointestinal><gastrointestinal disorder><genetic approach><genetic risk factor><genetic strategy><gitter cell><glial activation><glial cell activation><gliogenesis><gut homeostasis><gut to brain axis><gut-brain axis><gut-brain communication><gut-brain interactions><gut-brain relationship><gut-brain signaling><hippocampal><host response><immune system response><immunoresponse><improved><infected with enteropathogen><inflammatory disease of the intestine><inflammatory disorder of the intestine><inherited factor><injuries><intelligence quotient deficit><interventional strategy><intestinal autoinflammation><intestinal barrier><intestinal infection><intestinal mucosal barrier><intestine infection><late onset alzheimer><mesoglia><microglial cell><microgliocyte><mild TBI><mild brain trauma><mild traumatic brain injury><motility disorder><nerve cell death><nerve cell loss><nerve cement><neural degeneration><neural inflammation><neurobehavioral><neurocognitive decline><neurocognitive impairment><neurodegeneration><neurodegenerative><neurodegenerative illness><neuroinflammation><neuroinflammatory><neurological degeneration><neurological dysfunction><neuron cell death><neuron cell loss><neuron death><neuron loss><neuronal cell death><neuronal cell loss><neuronal death><neuronal degeneration><neuronal loss><neuropathologic><neuropathological><neuropathology><neurotoxic><novel><overexpress><overexpression><pathophysiology><pathway><perivascular glial cell><permissiveness><pharmacologic><population based><primary degenerative dementia><progressive neurodegeneration><protective effect><receptor><resistant><response><senile dementia of the Alzheimer type><sex><small molecule><social role><synergism><transcutaneous stimulation><transdermal stimulation><traumatic brain damage>